A Study of 18F-AV-45 in Healthy Volunteers

Status:
Completed

Trial end date:
2008-01-01

Target enrollment:

Participant gender:

This study will determine how florbetapir F 18 (18F-AV-45) radioactivity is distributed throughout the body.

Phase 1

Avid Radiopharmaceuticals